JP2006316006A - Chitosan compounded composition and food - Google Patents

Chitosan compounded composition and food Download PDF

Info

Publication number
JP2006316006A
JP2006316006A JP2005141083A JP2005141083A JP2006316006A JP 2006316006 A JP2006316006 A JP 2006316006A JP 2005141083 A JP2005141083 A JP 2005141083A JP 2005141083 A JP2005141083 A JP 2005141083A JP 2006316006 A JP2006316006 A JP 2006316006A
Authority
JP
Japan
Prior art keywords
chitosan
extract
constipation
composition
seed oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005141083A
Other languages
Japanese (ja)
Other versions
JP4830130B2 (en
Inventor
Yuuji Maesaki
祐二 前崎
Teruo Yoshiyuki
輝郎 吉行
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ART FOODS KK
Nippon Kayaku Co Ltd
Original Assignee
ART FOODS KK
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ART FOODS KK, Nippon Kayaku Co Ltd filed Critical ART FOODS KK
Priority to JP2005141083A priority Critical patent/JP4830130B2/en
Publication of JP2006316006A publication Critical patent/JP2006316006A/en
Application granted granted Critical
Publication of JP4830130B2 publication Critical patent/JP4830130B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

<P>PROBLEM TO BE SOLVED: To solve the problems of chitosan having physiological activities such as cholesterol controlling action at the risk of the constipation side action to cause the difficulty in continuous administration in certain people and the problems of a constipation ameliorating food containing Aloe arborescens extract and chitosan, effective simply for ameliorating constipation, useless for the continuous administration of chitosan and causing side action of aloe such as soft feces and diarrheain certain people, and develop a safe chitosan composition enabling continuous administration of chitosan without causing the constipation side action, free from the side action of diarrhea, etc., by the compounded drug and enabling the administration of the composition for a long period. <P>SOLUTION: The composition solving the above problems contains chitosan in combination with (a) hempseed oil and/or (b) seed of Cassia obtusifolia L. or Cassia tora L. or its extract. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

本発明は、キトサン配合組成物及び食品、より具体的には配合成分として(1)キトサンと、(2)(a)麻の実油及びケツメイシ若しくはそのエキスのいずれか一種若しくは両者、を含有することを特徴とする組成物及び食品に関する。   The present invention contains a chitosan blended composition and food, more specifically, (1) chitosan as a blending component, and (2) (a) any one or both of hempseed oil and ketsumeishi or an extract thereof. The present invention relates to a composition and a food product.

キトサンはカニ、エビ、オキアミなどの甲殻類の甲皮、カブトムシ、バッタなどの昆虫類の甲皮、イカの骨を希酸による脱カルシウム処理、希アルカリによる除たん白処理を行い得られたキチンを濃アルカリにより脱アセチル化処理して得られる多糖である。キトサンの構造はセルロース、ヘミセルロースに類似しており、食物繊維の定量法である酵素−重量法(プロスキー法)で定量するとその大部分は消化酵素で分解されず食物繊維として定量される。キトサンはヒトにおいて血清コレステロール値の改善(Biosci. Biotech. Biochem. , 57, 1439-1444,(1993)、キチン・キトサン研究、1(3)、175-183、(1995)、キチン・キトサン研究、2(1)、1-8、(1996)、健康・栄養食品研究、2(1)、27-36、(1999))及び腸内腐敗産物の抑制作用( Microbial Ecology in Health and Disease, 8, 15-21, (1995)等を持つことが報告されている。近年では、キトサンの持つこれら生体調整機能を期待した特定保健用食品や多くの栄養補助食品が発売されているため、キトサンを日常的に摂取する機会が増えてきている。キトサンは構造式にアミノ基を有しており、胆汁酸などの様々な酸性物質を吸着する働きがあり、この働きは降コレステロール薬剤であるコレスチラミンと同じものである。
生体内でキトサンと同じ作用を示すコレスチラミンは便秘の副作用を有しているが(アベンティスファーマ■、コレスチラミン製剤”クエストラン”貼付文章)、キトサンにおいても人により摂取後に便秘の症状を訴える人がみられる。便秘の症状を生じた場合は食餌療法としてとしてヨーグルトなどの乳酸菌の入った飲料や乳製品の摂取、又は、食物繊維が豊富に含まれている野菜を摂取し、同時に適度な運動により腸を活性化することが大切であるが、改善されない場合は下剤の服用が一般的である。キトサンを摂取して便秘の症状を訴えた場合も、これらの食物などを同時摂取することが推奨されるが、現在、流通しているキトサン食品は携帯に便利な錠剤やソフトカプセル等の形態が殆どであり、キトサンを摂取する度に便秘を予防するための上記の食品を同時に摂取することは、キトサン食品が実際に使用される場面においては難しい。食物繊維や乳酸菌を含有した健康食品を同時に摂取することも考えられるが、摂取粒数が多くなることや、経済的負担が増える等の問題がある。また、日常的な運動においても交通手段のIT化、機械化が進んだ現代社会において、特に都市部に住んでいる人にとっては実施することが困難である。
Chitosan is a chitin obtained by decalcification treatment with dilute acid and decalcification treatment with dilute alkali on crustacean crust such as crab, shrimp, krill, insect crust like beetle, grasshopper and squid bone. Is a polysaccharide obtained by deacetylation treatment with concentrated alkali. The structure of chitosan is similar to cellulose and hemicellulose, and most of it is quantified as dietary fiber without being digested by digestive enzymes when quantified by the enzyme-weight method (Prosky method), which is a dietary fiber quantification method. Chitosan improves serum cholesterol levels in humans (Biosci. Biotech. Biochem., 57, 1439-1444, (1993), chitin chitosan research, 1 (3), 175-183, (1995), chitin chitosan research, 2 (1), 1-8, (1996), Health and Nutrition Food Research, 2 (1), 27-36, (1999)) and the inhibitory action of intestinal spoilage products (Microbial Ecology in Health and Disease, 8, 15-21, (1995), etc. In recent years, foods for specified health use and many dietary supplements that are expected to have these bioregulatory functions of chitosan have been released. The chitosan has an amino group in its structural formula and has the function of adsorbing various acidic substances such as bile acids, which works with cholestyramine, a cholesterol-lowering drug. The same thing.
Cholestyramine, which has the same action as chitosan in vivo, has side effects of constipation (Aventis Pharma ■, cholestyramine preparation "Questlan" affixed text), but also in chitosan who complains of constipation after ingestion Is seen. If you have symptoms of constipation, take a drink or dairy product containing lactic acid bacteria such as yogurt as a dietary therapy, or ingest vegetables that are rich in dietary fiber, and at the same time activate the intestines by moderate exercise It is important to use a laxative if it is not improved. Even when chitosan is ingested and complains of symptoms of constipation, it is recommended to take these foods at the same time. However, currently available chitosan foods are mostly in the form of tablets and soft capsules that are convenient to carry. It is difficult to take the above-mentioned food for preventing constipation at the same time when chitosan is taken in a scene where chitosan food is actually used. Although it is conceivable to simultaneously take in healthy foods containing dietary fiber and lactic acid bacteria, there are problems such as an increase in the number of grains taken and an increase in the economic burden. Moreover, even in daily exercise, it is difficult to carry out in a modern society where transportation has become IT and mechanized, especially for people living in urban areas.

また、キトサンに、瀉下作用を有する物質を配合した食品としては、便秘の人の便性状改善に、アロエとキトサンを同時摂取することで、アロエの瀉下作用で、便秘改善をはかると共に、キトサンの作用で胃腸の調子を整えて下痢を伴なわず、便臭を軽減する便秘改善用食品が提案されている(特許文献1参照)。しかし、該便秘改善用食品はあくまで便秘の改善用であり、便秘でない人のキトサンの継続的摂取を目的としたものではなく、便秘でない人が摂取した場合には、人によっては、下痢等の症状を生じる怖れもあり、便秘でない人のキトサンの継続的摂取のためには適しているとは言い難い。例えば、該便秘改善用食品においては、キダチアロエエキス中のアロイン(バルバロイン)の瀉下作用により、人によっては便秘の人が、今度は逆に泥状や水状の下痢状便となる人が確認されている。従って、便秘を生ずること無しにキトサン摂取を継続的に出来るようにしたキトサン組成物は知られていない。   In addition, as a food containing a substance with a coughing action in chitosan, by taking aloe and chitosan at the same time to improve the stool properties of constipated people, the swallowing action of aloe improves the constipation, and the chitosan A food for improving constipation has been proposed in which the gastrointestinal tone is adjusted by action to reduce stool odor without diarrhea (see Patent Document 1). However, the food for improving constipation is only for improving constipation, and is not intended for continuous intake of chitosan by non-constipated people. There are fears of causing symptoms, and it is not suitable for continuous intake of chitosan for non-constipated people. For example, in the food for improving constipation, due to the swallowing action of aloin (barbaroin) in Kidachi aloe extract, some people are confirmed to be constipated, and this time people who become mud or watery diarrheal stools are confirmed. Has been. Therefore, there is no known chitosan composition that allows continuous intake of chitosan without causing constipation.

特開2001−252046号公報JP 2001-252046 A

前記のように、キトサンはコレステロール調整作用等の有用な生理活性を有するにもかかわらず、上記のように、キトサンによる便秘の副作用が無く、且つ、配合する薬剤による下痢等の副作用生じない、継続的にキトサンの摂取可能な、安全なキトサン製剤若しくはキトサン含有食品は見いだされおらず、そのようなキトサン製剤若しくはキトサン含有食品の開発が望まれている。   As described above, although chitosan has useful physiological activities such as cholesterol regulating action, as described above, there is no side effect of constipation due to chitosan, and no side effects such as diarrhea due to the drug to be mixed occur. In particular, no safe chitosan preparation or food containing chitosan that can be ingested by chitosan has been found, and development of such a chitosan preparation or food containing chitosan is desired.

そこで本発明者らは種々検討した結果、キトサンと麻の実油及び/又はケツメイシ若しくはケツメイシエキス(以下場合により単に、有効成分ともいう)を同時に摂取することで、キトサン摂取による便秘の副作用を防止出来ると共に、配合薬剤による下痢などの副作用も生じることがなく、キトサンを安全に且つ継続的に摂取可能なことを見出した。 本発明は上記知見に基づいて完成されたものである。
即ち、本発明は、
1.配合成分として下記(1)及び(2)
(1)キトサン
(2)(a)麻の実油及び、(b)ケツメイシ若しくはそのエキス、のいずれか一種若しくは両者、
を含有することを特徴とする組成物、
2.キトサン、麻の実油及びケツメイシを含有する請求項1に記載の組成物、
3.キトサン、麻の実油及びケツメイシエキスを含有する請求項1に記載の組成物、
4.キトサンが20mPa・s以上の高分子キトサンである請求項1〜3のいずれか一項に記載の組成物、
5.組成物が液剤、粉剤、顆粒剤、カプセル剤又は錠剤である請求項1〜4のいずれか一項に記載の組成物、
6.配合成分として下記(1)及び(2)
(1)キトサン
(2)(a)麻の実油及び、(b)ケツメイシ若しくはそのエキス、のいずれか一種若しくは両者、
を含有することを特徴とする食品、
7.キトサン、麻の実油及びケツメイシを含有する請求項6に記載の食品、
8.キトサン、麻の実油及びケツメイシエキスを含有する請求項6に記載の食品、
9.キトサンが20mPa・s以上の高分子キトサンである請求項6〜8のいずれか一項に記載の食品、
に関する。
Therefore, as a result of various studies, the present inventors have prevented the side effect of constipation due to ingestion of chitosan by simultaneously ingesting chitosan and hemp seed oil and / or ketsumeishi or ketsumeishi extract (hereinafter also simply referred to as an active ingredient). It was found that chitosan can be safely and continuously ingested without causing side effects such as diarrhea due to the combination drug. The present invention has been completed based on the above findings.
That is, the present invention
1. The following ingredients (1) and (2)
(1) Chitosan (2) (a) Hemp seed oil and (b) Ketsumeishi or its extract, either one or both,
A composition comprising:
2. The composition according to claim 1, comprising chitosan, hemp seed oil and ketsumeishi,
3. The composition according to claim 1, comprising chitosan, hemp seed oil and ketsumeishi extract,
4). The composition according to any one of claims 1 to 3, wherein the chitosan is a high-molecular chitosan of 20 mPa · s or more.
5. The composition according to any one of claims 1 to 4, wherein the composition is a liquid, a powder, a granule, a capsule, or a tablet.
6). The following ingredients (1) and (2)
(1) Chitosan (2) (a) Hemp seed oil and (b) Ketsumeishi or its extract, either one or both,
A food characterized by containing,
7). The food according to claim 6, comprising chitosan, hemp seed oil and katsumei
8). 7. The food according to claim 6, comprising chitosan, hemp seed oil and ketsumeishi extract,
9. The food according to any one of claims 6 to 8, wherein the chitosan is a polymeric chitosan having a viscosity of 20 mPa · s or more.
About.

本発明の、キトサンと共に、麻の実油及び/又はケツメイシ若しくはそのエキスを含有した組成物は、キトサン摂取による便秘の副作用を防止すると共に、配合薬剤による下痢などの副作用も生じることがないことから、キトサンを、安全に且つ継続的に摂取することを可能にするものである。   The composition containing hemp seed oil and / or ketsumeishi or an extract thereof together with chitosan according to the present invention prevents side effects such as diarrhea caused by a combination drug while preventing side effects of constipation due to ingestion of chitosan. The chitosan can be taken safely and continuously.

本発明において使用されるキトサンは、通常、例えば、カニ、エビ等の甲殻類の甲皮等を原料とし、それを希アルカリ又は酵素で脱蛋白し、さらに希酸で脱カルシウムして灰分を取り除きキチンを得た後、キチンを水酸化ナトリウム、水酸化カリウム等の強アルカリ剤中で脱アセチル化した後、数回水洗することによって得られるが、特にこの方法に限定されない。また、製造されたキトサンは、粘度として5mPa・s以上(0.5W/W%の0.5%酢酸水溶液)であれば凝集効果もあるので使用可能と考えられるが、キトサンのコレステロール調整効果の点から、20mPa・s以上が好ましく、より好ましくは100mPa・s以上の高分子がよい。本発明に用いられるキトサンは、例えば、日本化薬フードテクノ株式会社、株式会社キミカ、甲陽ケミカル株式会社、大日精化工業株式会社などのキトサンメーカーから購入する事が出来る。   The chitosan used in the present invention is usually made from, for example, crustacean crusts such as crabs and shrimp, deproteinized with dilute alkali or enzyme, and decalcified with dilute acid to remove ash. After obtaining chitin, it is obtained by deacetylating chitin in a strong alkali agent such as sodium hydroxide or potassium hydroxide and then washing with water several times, but it is not particularly limited to this method. The chitosan produced is considered to be usable because it has an aggregating effect if it has a viscosity of 5 mPa · s or more (0.5 W / W% 0.5% acetic acid aqueous solution). From the viewpoint, a polymer of 20 mPa · s or more is preferable, and a polymer of 100 mPa · s or more is more preferable. Chitosan used in the present invention can be purchased from chitosan manufacturers such as Nippon Kayaku Food Techno Co., Ltd., Kimika Co., Ltd., Koyo Chemical Co., Ltd., and Dainichi Seika Kogyo Co., Ltd.

本発明に使用する麻の実油(大麻油)は大麻(学名:Cannabis Sativa L.)の種子から得られる食用に適した油であれば特に制限はない。通常は該種子から機械的に圧搾して油を搾り出し、更に溶剤(食品添加物であるヘキサン)で残った油を抽出して得ることができる。また、圧搾を行わず最初から溶剤で油分を抽出してもよい。さらには、低温圧搾法(コールドプレス)を用いると成分の劣化が少ない良質の麻の実油を得ることができる。また、これらの油を以下の工程で精製して使用しても良い。すなわち、搾取した油に水を加えガム質を分離後、遠心分離機で除去し、原油を得た後、リン酸を加え残存するガム質を除去し、水酸化ナトリウムを加えて遊離している脂肪酸を除去後、水洗した後活性白土等を加えて撹拌し、葉緑素等の色素を吸着させ、ろ過をして白土を除去して脱色する。こうして得られた油を冷却し、析出する固体の油脂やロウ分を除去後、高温・真空下で水蒸気蒸留によって有臭成分を取り除き(脱臭)し精製する。なお、精製方法はこの方法に限定されるものではなく、カラム等を用いた精製法でも構わない。本発明における麻の実油の使用量は、キトサン10質量部に対して1質量部から100質量部(以下、部は特に断りのない限り質量部を表す)程度の範囲であれば良いが、好ましくは2部以上、より好ましくは5部以上、更に場合により8部以上で、かつ、50部以下、より好ましくは20部以下である。好ましい範囲としては5部〜20部以下である。本発明に用いられる麻の実油は、例えば、順成産業株式会社(商品名:麻の実油)から購入し入手する事が出来る。   The hemp seed oil (cannabis oil) used in the present invention is not particularly limited as long as it is an edible oil obtained from cannabis (scientific name: Cannabis Sativa L.) seeds. Usually, the oil can be obtained by extracting the remaining oil with a solvent (hexane, which is a food additive) by squeezing the seed mechanically. Moreover, you may extract an oil component with a solvent from the beginning, without pressing. Furthermore, if a low temperature pressing method (cold press) is used, a good quality hemp seed oil with little deterioration of components can be obtained. Moreover, you may refine | purify and use these oils at the following processes. That is, after adding water to the extracted oil and separating the gum, it is removed with a centrifuge, and after obtaining crude oil, phosphoric acid is added to remove the remaining gum, and sodium hydroxide is added to release it. After removing the fatty acid, washing with water, adding activated clay, etc., stirring, adsorbing pigments such as chlorophyll, filtering, removing the clay, and decolorizing. The oil thus obtained is cooled, and after removing the solid fats and waxes that precipitate, the odorous components are removed (deodorized) by steam distillation at high temperature and under vacuum to purify the oil. The purification method is not limited to this method, and a purification method using a column or the like may be used. The amount of hemp seed oil used in the present invention may be in the range of about 1 to 100 parts by mass (hereinafter, parts represent parts by mass unless otherwise specified) with respect to 10 parts by mass of chitosan, Preferably it is 2 parts or more, more preferably 5 parts or more, further 8 parts or more in some cases, and 50 parts or less, more preferably 20 parts or less. A preferred range is 5 to 20 parts. The hemp seed oil used in the present invention can be purchased and obtained from Junsei Sangyo Co., Ltd. (trade name: hemp seed oil), for example.

本発明に使用するケツメイシはハブ茶の原料であるエビスグサ(学名:Cassia obtusifolia L.)またはCassia tora L.の成熟種子を乾燥したものであれば特に制限はなく、ケツメイシエキスはこれらの成熟種子、例えば乾燥物より、抽出されたエキスを含むものであれば特に制限はない。例えば抽出液、その濃縮エキス、乾燥粉末エキス等が挙げられる。通常熱水または冷水で抽出して得られるエキスを含むものが好ましい。また、乾燥粉末エキスは、例えばエキスを含む抽出液若しくはの濃縮液を凍結乾燥またはスプレードライで粉末化するか、又はエキスを含む抽出液若しくは濃縮液にデキストリン、還元麦芽糖、可溶性でんぷん、メチルセルロースなどの賦形剤を加えて粉末化しても良い。
本発明で用いるケツメイシ若しくはそのエキス量は、キトサン3500部に対して、ケツメイシエキス(乾燥物)換算で、1部から140部程度の範囲であれば良いが、好ましくは10部以上、より好ましくは20部以上で、100部以下、より好ましくは40部以下である。従って好ましい範囲としては、10部から100部、より好ましくは20部〜40部である。本発明に用いられるケツメイシは、例えば、丸善製薬株式会社(製品名:決明子エキスパウダーMF)から購入し入手する事が出来る。
There is no particular limitation on the ketsumeishi used in the present invention as long as it is a dried mature seed of Ebisugusa (scientific name: Cassia obtusifolia L.) or Cassia tora L. which is a raw material of hub tea. For example, there is no particular limitation as long as it contains an extract extracted from a dried product. For example, an extract, its concentrated extract, a dry powder extract, etc. are mentioned. Usually, those containing an extract obtained by extraction with hot water or cold water are preferred. The dry powder extract is prepared by, for example, pulverizing an extract or concentrate containing the extract by freeze-drying or spray-drying, or adding dextrin, reduced maltose, soluble starch, methylcellulose, etc. to the extract or concentrate containing the extract. An excipient may be added to form a powder.
The amount of Ketsumeishi or its extract used in the present invention may be in the range of about 1 part to 140 parts in terms of Ketsumeishi extract (dry matter) with respect to 3500 parts of chitosan, preferably 10 parts or more, more preferably 20 parts or more, 100 parts or less, more preferably 40 parts or less. Accordingly, the preferred range is 10 to 100 parts, more preferably 20 to 40 parts. Ketsumeishi used in the present invention can be purchased and obtained from, for example, Maruzen Pharmaceutical Co., Ltd. (product name: Seimeiko Extract Powder MF).

本発明の組成物は、組成物中に、キトサンと共に、麻の実油又はケツメイシ若しくはそのエキスの少なくともいずれか一方を含めばよいが、より好ましい態様においては麻の実油及びケツメイシ若しくはそのエキスの両者を含むものである。キトサンと共に、麻の実油及びケツメイシ若しくはそのエキスの両者を含む組成物においても、麻の実油及びケツメイシ若しくはそのエキスのキトサンに対する割合は上記の記載した割合でよい。
本発明の組成物は有効成分だけでなっていてもよいが、通常は賦形剤などの添加剤と共に製剤化された組成物又は、有効成分を配合した食品等である。
The composition of the present invention may contain at least one of hemp seed oil or ketsumeishi or an extract thereof together with chitosan in a composition. In a more preferred embodiment, the composition of hemp seed oil and ketsumeishi or an extract thereof is included. It includes both. In the composition containing both hemp seed oil and ketmeishi or its extract together with chitosan, the ratio of hemp seed oil and ketmeishi or its extract to chitosan may be the ratio described above.
The composition of the present invention may be composed of only active ingredients, but is usually a composition formulated with additives such as excipients, or a food containing the active ingredients.

本発明の製剤化された組成物としては、ドリンク等の液剤、粉剤、顆粒剤、カプセル剤、錠剤など常法で、賦形剤などの添加剤と共に製剤化されたものが挙げられる。また、食品としては、特に限定されないが通常は麺類、パン類、ハム、ソーセージ、かまぼこ又はハンバーグ等の肉加工品類、惣菜類、ビスケット等の菓子類、ジュース類などの飲み物類等が挙げられ、食品であれば何れでもよい。食品等にキトサンを添加する場合、キトサンは通常粉末状、フレーク状、有機酸水溶液に溶解した溶液状等で添加される。該組成物には、上記有効成分以外に、乳糖、デンプン、食用卵殻粉、ドロマイトなどの増量剤、メチルセルロース、可溶性デンプン、ゼラチンなどの結着剤、セルロース、粉砕小麦ふすま、寒天などの崩壊剤、グリセリン脂肪酸エステル、タルク、ステアリン酸マグネシウムなどの滑沢剤、セラック、メチルセルロース等のコーティング基剤、クエン酸、リンゴ酸、ビタミンCなどの酸味料、ショ糖、果糖、還元麦芽糖、ソルビトール、アスパルテームなどの甘味料、香料等の製剤用添加物及び/又は食品素材等を必要に応じて適宜含むことができる。これらの組成物中における含量は、キトサン、麻の実油、ケツメイシ若しくはそのエキスの含量を除いた残部となるが、その量は組成物中に通常0〜99.9%(質量:以下同じ)の範囲である。従って、本発明組成物における有効成分含量は100〜0.1%である。又、キトサンは粉末状、フレーク状、有機酸水溶液に溶解して添加してもよい。  Examples of the formulated composition of the present invention include those formulated with additives such as excipients by conventional methods such as liquids such as drinks, powders, granules, capsules and tablets. In addition, the food is not particularly limited, and usually includes noodles, breads, ham, sausage, processed meat products such as kamaboko or hamburger, side dishes, confections such as biscuits, drinks such as juices, etc. Any food may be used. When chitosan is added to food or the like, chitosan is usually added in the form of powder, flakes, or a solution dissolved in an organic acid aqueous solution. In addition to the above active ingredients, the composition includes fillers such as lactose, starch, edible eggshell powder, dolomite, binders such as methylcellulose, soluble starch and gelatin, disintegrants such as cellulose, ground wheat bran and agar, Lubricants such as glycerin fatty acid esters, talc and magnesium stearate, coating bases such as shellac and methylcellulose, acidulants such as citric acid, malic acid and vitamin C, sucrose, fructose, reduced maltose, sorbitol, aspartame, etc. Additives for preparations such as sweeteners and fragrances and / or food materials can be included as necessary. The content in these compositions is the remainder excluding the content of chitosan, hemp seed oil, ketmeishi or its extract, but the amount is usually 0 to 99.9% in the composition (mass: the same below) Range. Therefore, the active ingredient content in the composition of the present invention is 100 to 0.1%. Chitosan may be added in the form of powder, flakes or an organic acid aqueous solution.

本発明組成物における有効成分含量は上記の範囲であればいずれでも特に問題はないが、キトサンの1日の摂取必要量が、単回、若しくは複数回の摂取によって、摂取できるように含まれているのが好ましい。1日の摂取必要量はその目的等により異なるので、一概にいうことは難しいが、例えば、10mg〜9g/成人程度、好ましくは100mg〜5g/成人程度、より好ましくは500mg〜2g/成人程度十分に摂取できように含まれていることが好ましい。
健康食品などの製剤化されたサプリメント等の場合は、例えば、固形製剤中に、キトサンが、製剤全体に対して5〜80%、好ましくは10〜50%程度であり、場合により、20〜45%程度である。他の有効成分はキトサンを基準にして、前記した割合の範囲で含むようにすればよい。なおカプセル製剤における場合、上記の割合はカプセルに充填する内容物の組成割合である。また、食品等における場合にはキトサン含量が食品中において通常0.1%以上、好ましくは0.2%以上で、上限は上記と同程度になる範囲で、摂取量、味覚等を考慮して決定される。
The active ingredient content in the composition of the present invention is not particularly limited as long as it is in the above range, but the daily intake of chitosan is included so that it can be ingested by single or multiple ingestion. It is preferable. The daily intake requirement varies depending on the purpose, etc., so it is difficult to say generally. For example, about 10 mg to 9 g / adult, preferably about 100 mg to 5 g / adult, more preferably about 500 mg to 2 g / adult It is preferable that it is contained so that it can be ingested.
In the case of formulated supplements such as health foods, for example, chitosan in the solid preparation is 5 to 80%, preferably about 10 to 50%, and in some cases 20 to 45%. %. Other active ingredients may be included in the above-described ratio range based on chitosan. In the case of a capsule preparation, the above ratio is the composition ratio of the contents filled in the capsule. In addition, in the case of food, etc., the chitosan content is usually 0.1% or more, preferably 0.2% or more in the food, and the upper limit is in the same range as above, taking the intake, taste, etc. into consideration. It is determined.

試験例
以下に試験例を挙げて本発明を具体的に説明するが、本発明はこれらに限定されるものではない。
(1)テスト用ソフトカプセルの製造
本発明の効果を確認するためにヒト摂取試験を行なうにあたり、下の表1に示したとおり4種類のソフトカプセルを製造した。コントロール食はキトサンのみ配合したもの、処方1はコントロールにケツメイシエキスを配合したもの、処方2はコントロールに麻の実油を配合したもの、そして処方3はコントロールにケツメイシエキスと麻の実油の双方を配合したものである。各処方はカプセル原料を除いて均一に分散・混合し、内容量が300mgとなるようにソフトカプセルに充填した。
Test Examples The present invention will be specifically described below with reference to test examples, but the present invention is not limited to these examples.
(1) Manufacture of test soft capsules In order to confirm the effects of the present invention, in conducting a human intake test, four types of soft capsules were manufactured as shown in Table 1 below. The control food contains chitosan only, the prescription 1 contains ketmeishi extract in the control, the prescription 2 contains hemp seed oil in the control, and the prescription 3 contains both ketmeishi extract and hemp seed oil in the control Are blended. Each formulation was uniformly dispersed and mixed, excluding the capsule raw material, and filled into soft capsules so that the inner volume was 300 mg.

Figure 2006316006
Figure 2006316006

(2)試験方法
20代から50代のランダムに選出した健康な男性8名、女性16名、計24名のモニターを性別、年齢が各グループに偏りがないように、4グループに分け、各グループそれぞれ1日当たりコントロールカプセル製剤10カプセルを1週間摂取させた後、グループ1には続けてコントロールカプセル製剤を、グループ2には処方1のカプセル製剤を、グループ3には処方2のカプセル製剤を、グループ4には処方3のカプセル製剤をそれぞれ1日10カプセル、21日間摂取させた。カプセルの摂取にあたっては1日摂取量10カプセルを自由な時間に水またはお湯で摂取させたが、まとめて10カプセルを摂取しても、数回に分けて摂取しても良いこととした。摂取前後の体調変化は摂取前、コントロールカプセル製剤摂取7日後、各試験カプセル製剤摂取7日後、14日後、21日後、摂取中止7日後の計6回、本人記入によるアンケートにより調査した。なお、本試験はヘルシンキ宣言の精神に則り、ボランティアには本試験の目的、内容、方法について十分に説明し、試験の参加の同意を得た上で実施した。
(2) Test method Randomly elected healthy men in their 20s to 50s, 16 women, and a total of 24 monitors, divided into 4 groups so that there is no bias in gender and age. After taking 10 capsules of the control capsule preparation per day for each group for one week, the control capsule preparation was continued in group 1, the capsule preparation of prescription 1 in group 2, the capsule preparation of prescription 2 in group 3, Group 4 was given 10 capsules per day for 21 days, respectively. In taking capsules, the daily intake of 10 capsules was taken in water or hot water at any time, but it was decided that 10 capsules could be taken together or in several divided doses. The change in physical condition before and after ingestion was investigated by questionnaires filled in by the person six times before ingestion, 7 days after ingestion of the control capsule preparation, 7 days after ingestion of each test capsule preparation, 14 days, 21 days, and 7 days after discontinuation of intake. The study was conducted in accordance with the spirit of the Declaration of Helsinki, and the volunteers were fully explained about the purpose, content, and method of the study, and consent was obtained from the study.

(3)アンケート項目
アンケートの項目は下に示す下表2示す評価基準により点数化して記入させた。
(3) Questionnaire items Questionnaire items were scored and entered according to the evaluation criteria shown in Table 2 below.

Figure 2006316006
Figure 2006316006

(4)試験結果
下表3に便量・便性スコアと排便回数を示す。キトサンのみを配合したコントロールカプセル製剤を1週間摂取すると、全てのグループで便量スコアは増加するが、便性は固く、排便回数も少なくなる傾向にあり、便秘の症状が出ていることを示している。しかしながら、この後に試験カプセル製剤を3週間摂取すると、コントロールにおいては便性や排便回数より便秘の傾向は改善されていないが、キトサンにケツメイシエキスを加えた処方1、キトサンに麻の実油を加えた処方2では、摂取7日後までは、便性と排便回数はほぼ、摂取前の状態に回復している。しかし、試験食を摂取しつづけると次第に便性・排便回数ともに便秘傾向を示すようになった。したがって、処方1及び処方2では一応の効果が認められるが長期にキトサンを摂取するには途中で摂取の中断等が必要なる可能性があり、より一層の改善の余地が認められた。一方、キトサンにケツメイシエキスと麻の実油を加えた処方3のカプセル製剤を摂取したグループ4においては、便性と排便回数は摂取前の状態を維持しており、キトサンによる便秘の副作用が抑制される共に、配合された麻の実油及び/又はケツメイシエキスによる泥状便等の副作用もなく、その効果が長期にわたって持続されることを示している。すなわち、この試験結果は、キトサンとケツメイシエキスの2種又はキトサンと麻の実油の2種を含む製剤においても一定の効果が認められ、一定期間の摂取のためには有効であるが、長期の継続的摂取のためにはキトサンと共に、麻の実油及びケツメイシ若しくはそのエキスの両者を含む組成物が最も適していることを示している。
(4) Test results The stool volume / fecal score and the number of defecations are shown in Table 3 below. When taking a control capsule formulation containing only chitosan for one week, the stool volume score increases in all groups, but the stool is hard and the number of defecations tends to decrease, indicating constipation symptoms. ing. However, after taking the test capsule preparation for 3 weeks, the tendency of constipation is not improved in the control due to the convenience and the number of defecations, but the formula 1 with Ketsumeishi extract added to chitosan and hemp seed oil added to chitosan In the prescription 2, until 7 days after ingestion, the stool property and the number of defecations are almost restored to the state before ingestion. However, as the test meal continued to be consumed, constipation and the number of bowel movements gradually showed constipation. Therefore, although the prescription 1 and prescription 2 have a temporary effect, ingesting chitosan for a long period of time may require an interruption of the intake, and there is room for further improvement. On the other hand, in Group 4 who took the capsule formulation of Formula 3 with Ketsumeishi extract and hemp seed oil added to chitosan, the stool properties and the number of defecations remained the same as before, and side effects of constipation due to chitosan were suppressed In addition, there is no side effect such as muddy feces due to the blended hemp seed oil and / or ketsumeishi extract, and it is shown that the effect is sustained over a long period of time. That is, this test result shows that a certain effect is observed even in a preparation containing two kinds of chitosan and ketsumeishi extract or two kinds of chitosan and hemp seed oil. It is shown that a composition containing both hemp seed oil and ketsumeishi or an extract thereof with chitosan is the most suitable for the continuous intake of.

Figure 2006316006
Figure 2006316006

以下に実施例を挙げて本発明を具体的に説明するが、本発明はこれらに限定されるものではない。   EXAMPLES The present invention will be specifically described below with reference to examples, but the present invention is not limited to these examples.

キトサン20.9kg、結晶乳糖20.9kg、結晶セルロース6.28kg、麻の実油10.47kg、ケツメイシエキス0.146kg、メチルセルロース1.19kgをスピードニーダーで混合後、水20kgを加え練合後、乾燥しスピードミルで整粒してキトサン顆粒を得た。   Mix 20.9kg of chitosan, 20.9kg of crystalline lactose, 6.28kg of crystalline cellulose, 10.47kg of hemp seed oil, 0.146kg of ketsumeishi extract and 1.19kg of methylcellulose, mix with 20kg of water, knead, dry and adjust with a speed mill. Granulated to obtain chitosan granules.

キトサン1g、小麦粉(中力粉)400g、麻の実油0.5g、ケツメイシエキス(2%品)粉末0.5g、塩5gをライカイ機で攪拌後、水200mlを加えてさらに攪拌して生地がまとまったら、製麺機で圧延し、12時間ねかしたあとに、切り出しを行なってキトサンうどんを得た。   Stir 1 g of chitosan, 400 g of wheat flour (medium flour), 0.5 g of hemp seed oil, 0.5 g of ketsumeishi extract (2% product) powder and 5 g of salt with a raikai machine, then add 200 ml of water and further stir the dough. Then, after rolling with a noodle making machine for 12 hours, it was cut out to obtain chitosan udon.

キトサン23.3kg、ケツメイシエキス(2%品)10.0kg、麻の実油33.3kg、小麦胚芽油20.0kg、ビタミンB21.7kg、ビタミンB61.3kg、ビタミンE(67%品)2.0kg、ミツロウ6.7kg、グリセリン脂肪酸エステル1.7kgを混合し、その300mgをソフトカプセルに充填してキトサン粒を得た。   Chitosan 23.3kg, Ketsumeishi extract (2% product) 10.0kg, Hemp seed oil 33.3kg, Wheat germ oil 20.0kg, Vitamin B 21.7kg, Vitamin B 61.3kg, Vitamin E (67% product) 2.0kg, Beeswax 6.7kg Then, 1.7 kg of glycerin fatty acid ester was mixed, and 300 mg of the mixture was filled into soft capsules to obtain chitosan granules.

キトサン1.0g、小麦粉200.0g、バター70.0g、麻の実油1.0g、ケツメイシエキス0.01g、ショ糖80.0g、卵50.0gを混合し圧延後にカッティングし、200℃のオーブンで焼いてキトサン配合ハードビスケットを得た。   Mixing chitosan 1.0g, wheat flour 200.0g, butter 70.0g, hemp seed oil 1.0g, ketsumeishi extract 0.01g, sucrose 80.0g, egg 50.0g, cutting after rolling, baking in a 200 ° C oven and hardened with chitosan I got a biscuit.

キトサン8.0g、豚ひき肉1000.0g、玉ねぎ(みじん切り)150.0g、麻の実油8.0g、ケツメイシエキス0.08g、塩20.0g、砂糖4.0g、こしょう3.5g、シーズニングスパイス10.0g、水120.0gを混合し、3時間4℃で放置した後に豚の腸の塩漬けに詰め、1本あたり約80gとなるように整形し、80℃の熱湯で20分過熱することでキトサン入りソーセージを得た。
Chitosan 8.0g, ground pork 1000.0g, onion (chopped) 150.0g, hemp seed oil 8.0g, ketsumeishi extract 0.08g, salt 20.0g, sugar 4.0g, pepper 3.5g, seasoning spice 10.0g, water 120.0g Then, after standing at 4 ° C for 3 hours, it was stuffed into salted pork intestines, shaped to about 80g per bottle, and overheated in hot water at 80 ° C for 20 minutes to obtain sausage with chitosan.

Claims (9)

配合成分として下記(1)及び(2)
(1)キトサン
(2)(a)麻の実油及び、(b)ケツメイシ若しくはそのエキス、のいずれか一種若しくは両者、
を含有することを特徴とする組成物。
The following ingredients (1) and (2)
(1) Chitosan (2) (a) Hemp seed oil and (b) Ketsumeishi or its extract, either one or both,
The composition characterized by containing.
キトサン、麻の実油及びケツメイシを含有する請求項1に記載の組成物。 The composition according to claim 1, comprising chitosan, hemp seed oil and ketsumeishi. キトサン、麻の実油及びケツメイシエキスを含有する請求項1に記載の組成物。 The composition according to claim 1, comprising chitosan, hemp seed oil and ketsumeishi extract. キトサンが20mPa・s以上の高分子キトサンである請求項1〜3のいずれか一項に記載の組成物。 The composition according to any one of claims 1 to 3, wherein the chitosan is a polymeric chitosan having a viscosity of 20 mPa · s or more. 組成物が液剤、粉剤、顆粒剤、カプセル剤又は錠剤である請求項1〜4のいずれか一項に記載の組成物。 The composition according to any one of claims 1 to 4, wherein the composition is a liquid, a powder, a granule, a capsule or a tablet. 配合成分として下記(1)及び(2)
(1)キトサン
(2)(a)麻の実油及び、(b)ケツメイシ若しくはそのエキス、のいずれか一種若しくは両者、
を含有することを特徴とする食品。
The following ingredients (1) and (2)
(1) Chitosan (2) (a) Hemp seed oil and (b) Ketsumeishi or its extract, either one or both,
A food product characterized by containing.
キトサン、麻の実油及びケツメイシを含有する請求項6に記載の食品。 The food according to claim 6, comprising chitosan, hemp seed oil and katsumeshi. キトサン、麻の実油及びケツメイシエキスを含有する請求項6に記載の食品。 The food according to claim 6, comprising chitosan, hemp seed oil and ketsumeishi extract. キトサンが20mPa・s以上の高分子キトサンである請求項6〜8のいずれか一項に記載の食品。
The food according to any one of claims 6 to 8, wherein the chitosan is a polymeric chitosan having a viscosity of 20 mPa · s or more.
JP2005141083A 2005-05-13 2005-05-13 Chitosan combination composition and food Active JP4830130B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005141083A JP4830130B2 (en) 2005-05-13 2005-05-13 Chitosan combination composition and food

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005141083A JP4830130B2 (en) 2005-05-13 2005-05-13 Chitosan combination composition and food

Publications (2)

Publication Number Publication Date
JP2006316006A true JP2006316006A (en) 2006-11-24
JP4830130B2 JP4830130B2 (en) 2011-12-07

Family

ID=37536990

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005141083A Active JP4830130B2 (en) 2005-05-13 2005-05-13 Chitosan combination composition and food

Country Status (1)

Country Link
JP (1) JP4830130B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100861587B1 (en) * 2008-02-15 2008-10-07 김미선 Compositions for makeup or cleansing which is composed from hemp-seed-oil and method for manufacturing the compositions
CN102688324A (en) * 2012-06-20 2012-09-26 李轩辕 Traditional Chinese medicine composition with functions of reducing fat and losing weight
CN103355726A (en) * 2013-08-01 2013-10-23 广西梧州市港圣堂保健食品有限公司 Plant beverage and preparation method therefor
JP2020513805A (en) * 2017-03-18 2020-05-21 マクガラー,スティーブン,エム. Pet food containing cannabidiol acid

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04281763A (en) * 1991-03-08 1992-10-07 Terumo Corp Composition for food and intestinal function-controlling food
JP2000041626A (en) * 1998-07-29 2000-02-15 Nakayama Gijutsu Kenkyusho:Kk Constipation disorder-improving food and drink in ingestion of chitosan
JP2001136910A (en) * 1999-11-11 2001-05-22 Itec:Kk Coffee beverage and processed beverage of the same, and additive preparation for coffee
JP2001178410A (en) * 1999-12-24 2001-07-03 Takashi Kondo Method for producing health food
JP2004500075A (en) * 2000-01-10 2004-01-08 シックソ リミテッド Concentrated oil composition of edible oil

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04281763A (en) * 1991-03-08 1992-10-07 Terumo Corp Composition for food and intestinal function-controlling food
JP2000041626A (en) * 1998-07-29 2000-02-15 Nakayama Gijutsu Kenkyusho:Kk Constipation disorder-improving food and drink in ingestion of chitosan
JP2001136910A (en) * 1999-11-11 2001-05-22 Itec:Kk Coffee beverage and processed beverage of the same, and additive preparation for coffee
JP2001178410A (en) * 1999-12-24 2001-07-03 Takashi Kondo Method for producing health food
JP2004500075A (en) * 2000-01-10 2004-01-08 シックソ リミテッド Concentrated oil composition of edible oil

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100861587B1 (en) * 2008-02-15 2008-10-07 김미선 Compositions for makeup or cleansing which is composed from hemp-seed-oil and method for manufacturing the compositions
CN102688324A (en) * 2012-06-20 2012-09-26 李轩辕 Traditional Chinese medicine composition with functions of reducing fat and losing weight
CN103355726A (en) * 2013-08-01 2013-10-23 广西梧州市港圣堂保健食品有限公司 Plant beverage and preparation method therefor
JP2020513805A (en) * 2017-03-18 2020-05-21 マクガラー,スティーブン,エム. Pet food containing cannabidiol acid

Also Published As

Publication number Publication date
JP4830130B2 (en) 2011-12-07

Similar Documents

Publication Publication Date Title
JP5824531B2 (en) Muscle atrophy inhibitor
JP2013075917A (en) Food containing glycogen and use thereof
JP5066670B2 (en) Anti-obesity agent and edible composition
JP4830130B2 (en) Chitosan combination composition and food
JP2011132151A (en) Composition for improving lipid metabolism
JP5779075B2 (en) Preventive agent for arthritis
JP2011148748A (en) Adiponectin secretion-promoting composition
JP2006056836A (en) Adipose tissue-specific secreted protein production-enhancing composition
CA2548379C (en) Compositions of galactomannan for the treatment of bowel diseases
JP2011219469A (en) Preventing and ameliorating agent for urinary tract infection
JP4889970B2 (en) Hyperphosphatemia preparation
JP2012171899A (en) Preventing and ameliorating agent for urinary tract infectious disease
JP7231898B2 (en) sleep quality improver
JP5222299B2 (en) Fat absorption inhibiting composition
JP2005046054A (en) Diet food and pharmaceutical preparation for diet
JP2008184459A (en) Calcium absorption accelerating composition
JP2006206474A (en) Functional food and medicine
CN104661669A (en) Pharmaceutical composition having preventative or treatment effect on inflammatory bowel diseases containing stemona root extract
JP2008120771A (en) Ameliorating agent for constipation
JP3345650B2 (en) Hypertension inhibitor
JP2012170342A (en) Taste quality improver
JP2010195734A (en) Phytic acid, carboxylic acid, and composition having fat absorption inhibitory action by synergistic effect of saccharides
JP2009084191A (en) Pharmaceutical composition for inhibiting appetite
JPH11147828A (en) Absorption inhibitor against cholesterol and lipid
JP2001252046A (en) Intestinal disorder or constipation-ameliorative food

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080324

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110524

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110715

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110816

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20110830

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110831

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20110830

R150 Certificate of patent or registration of utility model

Ref document number: 4830130

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140930

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250